Log in
Start free trial
Book a demo
Product
Media Database
Find the right journalists
Online Newsroom
Shape your own narrative
Press Release Creator
Create and send press releases
Media Monitoring
Track every single online mention
Media Pitching Tool
Contact recommendations & stats
PR Reports
Showcase the impact of your work
PR CRM
Manage contacts in easy way
AI PR Software
Use AI to save time on your workflow
Social Media Listening
Get a full overview of your brand's presence
Pricing
Top journalists
Top outlets
Book a demo
Log in
Start free trial
Media Database
>
Emily le Coz
Emily le Coz
Author at USA TODAY at
For The Win - USA Today
Contact this person
Email address
l*****@*******.com
Get email address
Influence score
39
Location
United States
Languages
English
Covering topics
View more media outlets and journalists by signing up to Prowly
View latest data and reach out all from one place
Sign up for free
Recent Articles
usatoday.com
How many ships hit bridges, lose power every year? Data shows jarring numbers on the rise.
An eerily accurate simulation of the Baltimore disaster at Cal Maritime showed the crew couldn’t avoid hitting the bridge under the same conditions.
9 months ago
usatoday.com
Baltimore bridge collapse wasn't first major accident for giant con...
The container ship that hit the Baltimore bridge on Tuesday was involved in a previous accident in 2016 when it slammed into a stone pier.
9 months ago
usatoday.com
CVS pharmacist Ashleigh Anderson's death at work becomes rallying c...
Ashleigh Anderson’s 2021 heart attack death while working as a CVS pharmacist became a viral tale of extreme pressure to hit corporate goals.
11 months ago
usatoday.com
Pharmacy chains ignored pleas to fix broken system. Now it's in rev...
Deteriorating working conditions inside the nation’s largest pharmacy chains have put patient safety at risk and plunged the profession into chaos.
about 1 year ago
usatoday.com
'No generics' deals blocked pet owners from cheaper flea-and-tick t...
Tevra Brands claimed Bayer schemed to keep generic versions of Advantage II and K9 Advantix II flea-and-tick products off the market. Bayer denied it.
over 1 year ago